PROBio-Techne Corp
stock72.56
+0.10 (+0.14%)
Price as of 13 Oct, 17:16 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Neutral
Mixed investment profile
Technical Analysis
Short-Term Outlook
Neutral
2 bull · 2 bear · 1 neutral
Medium-Term Outlook
Bullish
3 bull · 1 bear · 0 neutral
Price above 50-day MA
Price above 200-day MA
Price above 12-day EMA
Price above 26-day EMA
Neutral momentum zone
MACD below signal line
%K below %D
Price near lower band — potential bounce
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
+0.10
Market Cap
11237065000
Exchange
NASDAQ
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Bio-Techne Corp
What is Bio-Techne Corp?
Bio-Techne Corp is a global life sciences company that develops and manufactures high-quality reagents, instruments, and services for the biomedical research and clinical diagnostic markets. Their products are essential for scientists working in drug discovery, genomics, and proteomics to help advance medical breakthroughs. By providing these specialized tools, the company supports academic and commercial labs worldwide in their efforts to solve complex health challenges.
Is Bio-Techne Corp a good investment?
The company benefits from a strong position in the growing biotech supply chain and a history of steady innovation, which can be attractive for long-term investors. However, potential risks include high valuation multiples and sensitivity to fluctuations in research funding and healthcare spending. Please note that this information is for educational purposes only and does not constitute personalized financial advice.
How do you invest in Bio-Techne Corp?
You can invest in Bio-Techne by purchasing its shares, which trade on the NASDAQ under the ticker symbol TECH, through any licensed online brokerage account. Alternatively, you may gain indirect exposure by investing in healthcare-focused mutual funds or exchange-traded funds (ETFs) that hold TECH in their portfolios. Ensure you research your preferred platform's fees and account minimums before initiating a trade.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for TECH — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 14 Oct 2026Targets
Famous Investors Holding TECH
Ken Griffin
650.5K sh · 0.0% of portfolio
$45.96M
NEW
Ken Griffin
315.4K sh · 0.0% of portfolio
$22.29M
NEW
Ken Griffin
51.9K sh · 0.0% of portfolio
$3.67M
NEW
Ken Griffin
32.2K sh · 0.0% of portfolio
$2.27M
NEW
Ray Dalio
26.8K sh · 0.0% of portfolio
$1.89M
NEW
Mario Gabelli
6.3K sh · 0.0% of portfolio
$441.6K
NEW
Ken Griffin
100 sh · 0.0% of portfolio
$7.1K
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.